Worsening of lichen myxedematosus during interferon alfa-2a therapy for chronic active hepatitis C

Journal of the American Academy of Dermatology

Volumn 38, Issue 5 I, 1998, Pages 760-761

  Rongioletti, F ^a   Rebora, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; RECOMBINANT ALPHA2 INTERFERON;

ADULT; ARTICLE; CASE REPORT; FEMALE; FIBROBLAST; HEPATITIS C; HUMAN; LICHEN; PAPULAR SKIN DISEASE; PRIORITY JOURNAL; SCLEROMYXEDEMA; SKIN BIOPSY;

EID: 0031949749     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70205-1     Document Type: Article

References (7)

1. H Preston TC Wright Interferon therapy for hepatitis C Lancet 348 1996 913 914
2. LW Chang M Liranzo WF Bergfeld Cutaneous side effects associated with interferon-alpha therapy: a review Cutis 56 1995 144
3. F Rongioletti A Rebora The cutaneous mucinoses KA Arndt PE Leboit JQ Robinson BU Wintroub Cutaneous medicine and surgery: an integrated program in dermatology 1996 WB Saunders Philadelphia 1832 1840
4. U Protzer FR Ochsendorf A Leopolder-Ochsendorf KH Holtermuller Exacerbation of lichen planus during interferon alpha-2a therapy for chronic active hepatitis C Gastroenterology 104 1993 903 905
5. J Funk T Langeland E Schrumpf LE Hanssen Psoriasis induced by interferon-alpha Br J Dermatol 125 1991 463 465
6. F Cozzolino M Torcia M Lucibello L Morbidelli M Ziche J Platt Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth J Clin Invest 91 1993 2504 2512
7. K Meissner U Weyer L Kowalzick J Altenhoff Successful treatment of primary progressive follicular mucinosis with interferon J Am Acad Dermatol 24 1991 848 850